9月26日，诺普信盘中上涨2.02%，截至10:24，报13.14元/股，成交8924.48万元，换手率0.88%，总市值 132.08亿元。 资金流向方面，主力资金净流入404.98万元，特大单买入605.33万元，占比6.78%，卖出480.94万元，占 比5.39%；大单买入2479.40万元，占比27.78%，卖出2198.81万元，占比24.64%。 诺普信今年以来股价涨20.77%，近5个交易日跌1.50%，近20日涨5.71%，近60日涨27.08%。 分红方面，诺普信A股上市后累计派现17.67亿元。近三年，累计派现6.53亿元。 机构持仓方面，截止2025年6月30日，诺普信十大流通股东中，香港中央结算有限公司位居第三大流通 股东，持股2325.63万股，为新进股东。南方中证1000ETF（512100）位居第九大流通股东，持股649.71 万股，为新进股东。华夏行业景气混合A（003567）退出十大流通股东之列。 责任编辑：小浪快报 今年以来诺普信已经1次登上龙虎榜，最近一次登上龙虎榜为5月27日，当日龙虎榜净买入8599.79万 元；买入总计2.76亿元 ，占总成交额比14.92%；卖出 ...

Core Viewpoint - Noposion's stock price has shown a positive trend this year, with a year-to-date increase of 19.58%, and the company has experienced significant trading activity recently [1][2]. Company Overview - Noposion Agricultural Science Co., Ltd. is located in Bao'an District, Shenzhen, Guangdong Province, and was established on September 18, 1999. It was listed on February 18, 2008. The company specializes in providing integrated agricultural protection products, technologies, and services, with main products including pesticide formulations, plant nutrition, and pesticide adjuvants [2]. - The revenue composition of Noposion includes fresh consumption products (49.14%), insecticides (18.67%), fungicides (15.42%), plant nutrition (8.26%), herbicides (5.80%), plant growth regulators and adjuvants (1.20%), other products (1.09%), crop series (0.26%), and agricultural services and trade (0.15%) [2]. Financial Performance - For the first half of 2025, Noposion achieved operating revenue of 3.679 billion yuan, representing a year-on-year growth of 8.20%. The net profit attributable to the parent company was 648 million yuan, reflecting a year-on-year increase of 17.35% [2]. - Since its A-share listing, Noposion has distributed a total of 1.767 billion yuan in dividends, with 653 million yuan distributed over the past three years [3]. Shareholder Information - As of June 30, 2025, Noposion had 43,800 shareholders, an increase of 21.47% from the previous period. The average circulating shares per person decreased by 17.01% to 17,944 shares [2]. - Among the top ten circulating shareholders, Hong Kong Central Clearing Limited is the third-largest shareholder with 23.2563 million shares, while Southern CSI 1000 ETF is the ninth largest with 6.4971 million shares, both being new shareholders [3].

南方中证1000ETF（512100）成立日期2016年9月29日，最新规模649.53亿。今年以来收益28.17%，同 类排名1822/4222；近一年收益72.87%，同类排名1263/3804；成立以来收益13.43%。 9月18日，诺普信涨5.04%，截至发稿，报13.34元/股，成交4.19亿元，换手率4.06%，总市值134.09亿 元。 资料显示，深圳诺普信作物科学股份有限公司位于广东省深圳市宝安区西乡水库路113号(仅作办公 用)，成立日期1999年9月18日，上市日期2008年2月18日，公司主营业务涉及农业植保产品、技术、服 务一体化提供商,主要产品包括农药制剂、植物营养、农药助溶剂等。主营业务收入构成为：生鲜消费 类49.14%，杀虫剂18.67%，杀菌剂15.42%，植物营养8.26%，除草剂5.80%，植物生长调节剂及助剂类 1.20%，其他1.09%，作物系列0.26%，农业服务及贸易0.15%。 从诺普信十大流通股东角度 数据显示，南方基金旗下1只基金位居诺普信十大流通股东。南方中证1000ETF（512100）二季度新进 十大流通股东，持有股数649.71万股，占流通股的比例为 ...

Company Overview - Shenzhen Noposion Crop Science Co., Ltd. is located in Bao'an District, Shenzhen, Guangdong Province, and was established on September 18, 1999. The company went public on February 18, 2008. Its main business involves providing integrated agricultural protection products, technology, and services, including pesticide formulations, plant nutrition, and pesticide adjuvants [2]. Business Performance - For the first half of 2025, Noposion achieved operating revenue of 3.679 billion yuan, representing a year-on-year growth of 8.20%. The net profit attributable to the parent company was 648 million yuan, with a year-on-year increase of 17.35% [2]. - The revenue composition includes fresh consumption products (49.14%), insecticides (18.67%), fungicides (15.42%), plant nutrition (8.26%), herbicides (5.80%), plant growth regulators and adjuvants (1.20%), other products (1.09%), crop series (0.26%), and agricultural services and trade (0.15%) [2]. Stock Performance - On September 16, Noposion's stock price increased by 2.37%, reaching 12.53 yuan per share, with a trading volume of 181 million yuan and a turnover rate of 1.86%. The total market capitalization is 12.595 billion yuan [1]. - Year-to-date, Noposion's stock price has risen by 15.17%, with a 5-day increase of 5.74%, a 20-day decline of 3.62%, and a 60-day increase of 19.56% [1]. Shareholder Information - As of June 30, 2025, the number of shareholders for Noposion was 43,800, an increase of 21.47% from the previous period. The average circulating shares per person decreased by 17.01% to 17,944 shares [2]. - The company has distributed a total of 1.767 billion yuan in dividends since its A-share listing, with 653 million yuan distributed over the past three years [3]. Institutional Holdings - Among the top ten circulating shareholders as of June 30, 2025, Hong Kong Central Clearing Limited is the third-largest shareholder with 23.2563 million shares, a new addition. Southern CSI 1000 ETF (512100) ranks as the ninth-largest shareholder with 6.4971 million shares, also a new addition. Huaxia Industry Prosperity Mixed Fund (003567) has exited the top ten circulating shareholders list [3].

Core Viewpoint - Shenzhen Noposion Agrochemical Co., Ltd. reported a revenue increase of 8.20% year-on-year for the first half of 2025, driven by growth in its specialty fresh consumption and pesticide formulation businesses [1][2]. Company Overview and Key Financial Indicators - The company did not distribute cash dividends or issue bonus shares for the reporting period [1]. - Total revenue for the first half of 2025 was approximately CNY 3.68 billion, compared to CNY 3.40 billion in the same period last year [2]. - Net profit attributable to shareholders increased by 17.35% to approximately CNY 648 million [2]. - The company’s total assets grew by 9.33% to approximately CNY 12.28 billion [2]. Business Operations - The company focuses on the specialty fresh consumption sector, particularly blueberries, and aims to establish a comprehensive supply chain for this product [3][4]. - Noposion has been enhancing its agricultural technology services and distribution channels, particularly in the pesticide formulation sector, to strengthen its market position [5][6]. Financial Performance Analysis - Revenue from the pesticide formulation business was approximately CNY 1.49 billion, representing a growth of 8.94% [8]. - The specialty fresh consumption business generated approximately CNY 1.82 billion, with an increase of 18.62% year-on-year [8]. - The company’s operating costs rose by 6.29% to approximately CNY 2.29 billion, reflecting the increase in revenue [8]. Competitive Advantages - The company has established a strong distribution network and technical service team, enhancing its ability to serve large agricultural producers [5]. - Noposion's focus on a single crop strategy allows for a more integrated approach to product and service offerings, which has been well-received by farmers [4][5]. - The company has invested in modern agricultural practices, including automated and technology-driven farming methods, which create high barriers to entry in the industry [4]. Cash Flow and Investment Activities - The net cash flow from operating activities was approximately CNY 254 million, a decrease of 20.19% compared to the previous year [8]. - The net cash flow from investment activities improved significantly, with a reduction in outflows by 65.03% [8]. - The net cash flow from financing activities decreased by 83.38%, indicating reduced borrowing [8].